Bob Dagher

Technik-/Wissenschafts-/F&E-Leiter bei BRAINSTORM CELL THERAPEUTICS INC.

Vermögen: 123 211 $ am 31.05.2024

55 Jahre

Health Technology

Consumer Services

Aktive Positionen von Bob Dagher

Unternehmen	Position	Beginn	Ende
BRAINSTORM CELL THERAPEUTICS INC.	Technik-/Wissenschafts-/F&E-Leiter	16.04.2024	-
BRAINSTORM CELL THERAPEUTICS INC.	Corporate Officer/Principal	17.07.2023	16.04.2024

Unternehmen	Position	Beginn	Ende
ENVERIC BIOSCIENCES, INC.	Technik-/Wissenschafts-/F&E-Leiter	06.12.2021	01.01.2023
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01.12.2019	01.12.2021
COVANCE INC.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2018	01.01.2019
MedAvante-ProPhase, Inc.	Technik-/Wissenschafts-/F&E-Leiter	-	-

Faculté De Médecine Necker Enfants Malades Université	Undergraduate Degree
Université de Bordeaux	Undergraduate Degree

International

Vereinigte Staaten	6
Frankreich	3

Operativ

Chief Tech/Sci/R&D Officer	4
Corporate Officer/Principal	2
Undergraduate Degree	2

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
ENVERIC BIOSCIENCES, INC.	Health Technology
BRAINSTORM CELL THERAPEUTICS INC.	Health Technology

Private Unternehmen	3
MedAvante-ProPhase, Inc.
Labcorp Drug Development, Inc. Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ.	Health Technology
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Health Technology